Browse Category

NASDAQ:SWTX News 9 January 2026

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome shares rose 7.4% to $21.97 Friday after recent Phase 3 data showed its lead drug varegacestat cut disease progression or death by 84% in desmoid tumor patients. The company plans to file for FDA approval in Q2 2026. Immunome also granted stock options to three new hires and will present at the J.P. Morgan Healthcare Conference on Jan. 14.

Stock Market Today

Xero share price (ASX:XRO) ends lower as tech rout grinds on; what investors watch next week

Xero share price (ASX:XRO) ends lower as tech rout grinds on; what investors watch next week

8 February 2026
Xero closed Friday down 0.4% at A$81.76, near last week’s low, as software stocks slumped. The S&P/ASX 200 Tech Index was set to end the week down about 12%, hitting levels last seen in December 2023. Global tech shares also fell, with nearly $1 trillion in value erased from U.S. software stocks since Jan. 28. Investors await fresh rate and inflation signals next week.
Huntington Bank taps ex-BNY risk boss Senthil Kumar as new chief risk officer

Huntington Bank taps ex-BNY risk boss Senthil Kumar as new chief risk officer

8 February 2026
Huntington Bank named Senthil Kumar chief risk officer, effective Feb. 16, as it enters a stricter regulatory category after closing its Cadence Bank merger on Feb. 2. Kumar replaces Helga Houston, who becomes senior executive adviser March 1. The merger brings Huntington’s assets to about $279 billion, triggering tougher oversight. No branch closures are planned before a mid-2026 systems conversion.
Go toTop